Tamtam Try Tamtam free
U.S. Physical Therapy, Inc. logo

U.S. Physical Therapy, Inc. account plan

Outpatient therapy clinics operation

At a glance

U.S. Physical Therapy runs 799 outpatient physical therapy clinics and an industrial injury prevention business, with FY2025 revenue of $781.0 million.

U.S. Physical Therapy (USPH), based in Houston, operates outpatient physical, occupational and speech therapy clinics and home-care practices for orthopedic, sports and work injuries, plus an industrial injury prevention business sold to employers. Clinics run as Clinic Partnerships in which USPH generally holds 65% to 75% and the managing physical therapist owns the rest. FY2025 net revenue was $781.0 million (+16.3%), operating income $86.7 million and net income attributable to USPH shareholders $39.6 million. The company had 780 clinics in 44 states and about 7,294 employees at 31 December 2025, and 799 clinics at 30 September 2026.

Business units

Strategic priorities

Hospital affiliations
Under two 10-year alliances announced in February 2026, 62 Metro clinics in New York joined the NYU Langone network and 10 clinics joined a Gulf Coast hospital system; all 72 were integrated by the end of Q3 2026. Management is in talks with more hospital systems.
Acquisitions of PT and IIP businesses
USPH keeps buying multi-clinic practices, home-care practices and IIP businesses; 2026 deals include 50% of an eight-clinic practice, 70% of an IIP business and 67% of a twelve-clinic practice.
Higher net rate per visit
Revenue per visit rose to $110.61 in Q3 2026 from $105.54, helped by hospital rates and workers' compensation PPO agreements.
Back-office efficiency
A new ERP for HR and accounting, centralised billing and collections into 2027, and the WelcomeWare front-desk technology rolled out in 420 locations.
Digital and hybrid care
The company is working on its own digital and hybrid offerings for 2027 and has hired a senior leader to find partners.

Latest results

In Q3 2026 net revenue rose 12.9% to $222.6 million, including $25.0 million of new hospital affiliation revenue; physical therapy revenue was $189.5 million (+12.7%) and IIP revenue $33.0 million (+13.8%). Adjusted EBITDA was $27.8 million (vs $23.9 million), while net income attributable to shareholders fell to $11.0 million from $13.1 million. Visits reached 33.4 per clinic per day. Over nine months revenue was $634.9 million (+9.8%). Full-year 2026 EBITDA guidance of $102 million to $106 million was reaffirmed.

Investments and deals

2026 clinic acquisitions
Three 2026 deals total $38 million of purchase price, including a 12-clinic practice bought for $16.4 million with $12 million of annual revenue.
$450 million credit facility
A five-year facility closed on 14 April 2026 ($175.0 million term loan and $275.0 million revolver, maturing 14 April 2031); borrowings were $246.6 million at 30 September 2026.
Share buybacks and dividend
306,256 shares were repurchased for $19.2 million in 2026, nearly completing the $25.0 million authorization; the quarterly dividend is $0.46.
Finance and HR systems
A new finance and HR system implementation, phased over time, with costs expected to continue into 2027.

Challenges and risks

Self-insured health benefit costs
Employee insurance claims expense was $7 million higher year to date in 2026, about 150 basis points of PT margin headwind in Q3, prompting labour reductions and discretionary spending cuts.
Medicare reimbursement
Medicare therapy rates were cut repeatedly from 2021 to 2025; 2026 brought about 1.75%, which equates to a 1.1% increase after the Medicare Advantage mix.
Therapist recruiting and wages
Workforce costs are the largest operating expense, and a tight labour market makes staffing the constraint on volume.
Partner put rights
Partners' put rights could force purchases of significant equity, and revaluation of redeemable non-controlling interests drove a GAAP loss per share of $1.04 in Q3 2026.
Healthcare regulation
Anti-Kickback, Stark Law, corporate practice of medicine and HIPAA rules apply, including to management and hospital arrangements.

What leadership says

“a very significant benefit to us”

Chris Reading, Chairman and CEO · Q3 2026 earnings call, 5 November 2026, on CMS phasing out the IPCI modifier

“We're in discussion with a great many right now”

Chris Reading, Chairman and CEO · Q3 2026 earnings call, 5 November 2026, on hospital system partnerships

“we feel confident that 2027 is going to look meaningfully different with the next few of these”

Chris Reading, Chairman and CEO · Q2 2026 earnings call, 6 August 2026

“we're not going to spend differently just because we have money available”

Chris Reading, Chairman and CEO · Q2 2026 earnings call, 6 August 2026, on M&A

Where a supplier can help

Hospital EMR and integration support
Moving clinics into hospital networks required staff to learn a new hospital-based EMR; more hospital deals mean more integration, training and data migration work.
Employee benefits cost control
Self-insured health claims running well above average point to stop-loss, benefits administration and care-navigation providers.
Clinician recruiting
Staffing is the constraint on volume, which suits therapist recruiting, staffing and university pipeline partners.
Billing, ERP and front-desk automation
Centralised billing, the new finance and HR system and the WelcomeWare rollout fit revenue-cycle, ERP and patient-intake software vendors.
Digital and hybrid care partners
The plan for digital and hybrid offerings in 2027, with a senior leader hired to find partners, opens a door for virtual PT and remote monitoring providers.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like U.S. Physical Therapy, Inc.?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about U.S. Physical Therapy, Inc.

What does U.S. Physical Therapy do?

USPH operates outpatient physical, occupational and speech therapy clinics and home-care practices across the U.S., and provides industrial injury prevention services to employers. It had 799 clinics at 30 September 2026.

What is U.S. Physical Therapy's revenue?

FY2025 net revenue was $781.0 million, up 16.3%. Nine-month 2026 revenue was $634.9 million, and full-year 2026 EBITDA guidance is $102 million to $106 million.

How many employees does U.S. Physical Therapy have?

About 7,294 people at 31 December 2025, of whom about 4,200 were full-time.

What is U.S. Physical Therapy's strategy?

It grows through clinic and IIP acquisitions, new clinics within its partnerships, and since 2026 long-term affiliations that bring its clinics into hospital systems' networks.

Who leads U.S. Physical Therapy?

Chris Reading is Chairman and CEO; Nchacha Etta was appointed Chief Financial Officer in September 2026.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)